A. V. Marton

527 total citations
20 papers, 439 citations indexed

About

A. V. Marton is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, A. V. Marton has authored 20 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Computational Theory and Mathematics. Recurrent topics in A. V. Marton's work include Cholinesterase and Neurodegenerative Diseases (7 papers), Computational Drug Discovery Methods (5 papers) and Enzyme function and inhibition (4 papers). A. V. Marton is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (7 papers), Computational Drug Discovery Methods (5 papers) and Enzyme function and inhibition (4 papers). A. V. Marton collaborates with scholars based in Canada, Hungary and United States. A. V. Marton's co-authors include W. Kalow, Robertson Davies, Csaba Szabó, Jon G. Mabley, Francisco García Soriano, Andrew L. Salzman, Lucas Liaudet, György Haskó, Pál Pacher and Prakash G. Jagtap and has published in prestigious journals such as Nature, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

A. V. Marton

18 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. V. Marton Canada 10 173 104 93 56 49 20 439
Anne Regazzetti France 16 304 1.8× 76 0.7× 47 0.5× 31 0.6× 33 0.7× 34 678
Armin Kern Germany 9 166 1.0× 62 0.6× 55 0.6× 10 0.2× 26 0.5× 11 453
Ramanujam Rajagopalan India 13 379 2.2× 106 1.0× 44 0.5× 11 0.2× 22 0.4× 25 700
Nicole Sabolovic France 13 203 1.2× 43 0.4× 100 1.1× 19 0.3× 15 0.3× 23 537
Kodihalli C. Ravindra United States 13 293 1.7× 77 0.7× 82 0.9× 12 0.2× 21 0.4× 22 699
Yoh Imai Japan 15 299 1.7× 36 0.3× 58 0.6× 6 0.1× 23 0.5× 32 589
Michaela Miksits Austria 8 168 1.0× 55 0.5× 54 0.6× 20 0.4× 26 0.5× 10 435
Peter Bünning Germany 11 480 2.8× 39 0.4× 137 1.5× 6 0.1× 34 0.7× 19 739
Katja Zebisch Germany 6 282 1.6× 41 0.4× 123 1.3× 17 0.3× 24 0.5× 7 645
P E Sanders United States 12 214 1.2× 35 0.3× 78 0.8× 7 0.1× 38 0.8× 20 526

Countries citing papers authored by A. V. Marton

Since Specialization
Citations

This map shows the geographic impact of A. V. Marton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Marton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Marton more than expected).

Fields of papers citing papers by A. V. Marton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Marton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Marton. The network helps show where A. V. Marton may publish in the future.

Co-authorship network of co-authors of A. V. Marton

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Marton. A scholar is included among the top collaborators of A. V. Marton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Marton. A. V. Marton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Marton, A. V., V. Faigl, Margit Kulcsár, et al.. (2009). Milk progesterone profiles, blood metabolites, metabolic hormones and pregnancy rates in Awassi ewes treated by gestagen + eCG at the early breeding season. Veterinární Medicína. 54(11). 507–516. 4 indexed citations
3.
Burakowski, Tomasz, et al.. (2004). Taurine chloramine modifies carrageenin- and casein-induced inflammation in the rat. Inflammation Research. 53(0). S23–S24. 3 indexed citations
4.
Lohinai, Zsolt, Jon G. Mabley, É Fehér, et al.. (2003). Role of the Activation of the Nuclear Enzyme Poly(ADP-Ribose) Polymerase in the Pathogenesis of Periodontitis. Journal of Dental Research. 82(12). 987–992. 18 indexed citations
5.
Mabley, Jon G., Pál Pacher, Lucas Liaudet, et al.. (2003). Inosine reduces inflammation and improves survival in a murine model of colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(1). G138–G144. 82 indexed citations
6.
Mabley, Jon G., Prakash G. Jagtap, Mauro Perretti, et al.. (2001). Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflammation Research. 50(11). 561–569. 118 indexed citations
7.
Humber, Leslie G., C. I. Chappel, A. V. Marton, M. Kraml, & J.-E. Dubuc. (1966). The Relationship between Structure and Activity in a Novel Series of Serum Cholesterol-Lowering Agents1. Journal of Medicinal Chemistry. 9(3). 329–337. 4 indexed citations
8.
Kraml, M., A. V. Marton, & D. Dvornik. (1965). Effect of Primidone (Mysoline) on Tissular Levels of Griseofulvin in the Rat. Experimental Biology and Medicine. 120(3). 678–679. 1 indexed citations
9.
Marton, A. V., E. Greselin, Morris L. Givner, & Katherine Voith. (1964). Effect of a Novel Hypocholesterolemic Agent,Trans-1,4-bis- (2- chlorobenzylaminomethyl)Cyclohexane Dihydrochloride (AY- 9944) on Adrenal Morphology. Endocrinology. 75(4). 469–476. 9 indexed citations
10.
Marton, A. V. & C. I. Chappel. (1964). Inhibition of drug metabolism in the mouse by a hypocholesterolemic agent, AY-9944. Cellular and Molecular Life Sciences. 20(9). 517–518. 4 indexed citations
11.
Marton, A. V., E. A. Sellers, & W. Kalow. (1962). EFFECT OF COLD ON RATS CHRONICALLY EXPOSED TO MALATHION. Canadian Journal of Biochemistry and Physiology. 40(1). 1671–1676. 4 indexed citations
12.
Marton, A. V. & W. Kalow. (1962). INTERACTION BETWEEN AROMATIC ESTERASE OF HUMAN SERUM AND BIVALENT METAL IONS. PubMed. 40(3). 319–324. 15 indexed citations
13.
Marton, A. V., E. A. Sellers, & W. Kalow. (1962). EFFECT OF COLD ON RATS CHRONICALLY EXPOSED TO MALATHION. Canadian Journal of Biochemistry and Physiology. 40(12). 1671–1676. 13 indexed citations
14.
Marton, A. V. & W. Kalow. (1962). INTERACTION BETWEEN AROMATIC ESTERASE OF HUMAN SERUM AND BIVALENT METAL IONS. Canadian Journal of Biochemistry and Physiology. 40(1). 319–324. 5 indexed citations
15.
Kalow, W. & A. V. Marton. (1961). Second-Generation Toxicity of Malathion in Rats. Nature. 192(4801). 464–465. 34 indexed citations
16.
Marton, A. V. & W. Kalow. (1960). Inhibitors of aromatic esterase of human serum. Biochemical Pharmacology. 3(2). 149–154. 17 indexed citations
17.
Davies, Robertson, A. V. Marton, & W. Kalow. (1960). THE ACTION OF NORMAL AND ATYPICAL CHOLINESTERASE OF HUMAN SERUM UPON A SERIES OF ESTERS OF CHOLINE. Canadian Journal of Biochemistry and Physiology. 38(6). 545–551. 69 indexed citations
18.
Davies, Robertson, A. V. Marton, & W. Kalow. (1960). THE ACTION OF NORMAL AND ATYPICAL CHOLINESTERASE OF HUMAN SERUM UPON A SERIES OF ESTERS OF CHOLINE. Canadian Journal of Biochemistry and Physiology. 38(1). 545–551. 14 indexed citations
19.
Marton, A. V. & W. Kalow. (1959). STUDIES ON AROMATIC ESTERASE AND CHOLINESTERASE OF HUMAN SERUM. Canadian Journal of Biochemistry and Physiology. 37(1). 1367–1373. 4 indexed citations
20.
Marton, A. V. & W. Kalow. (1959). STUDIES ON AROMATIC ESTERASE AND CHOLINESTERASE OF HUMAN SERUM. Canadian Journal of Biochemistry and Physiology. 37(11). 1367–1373. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026